A 22 years old female presented with primary amenorrhea, short stature, widely spaced nipples and webbed neck. The Karyotype is:
Ans. c. 45, XO (Ref: Shaw 14/e p96-97)A 22 years old female presented with primary amenorrhea, short stature, widely spaced nipples and webbed neck. The patient is suffering from Turners syndrome and karyotype is 45, XO.A 16-year old female presents with primary amenorrhea and raised FSH level. On examination, her height was 58 inches. Most probable diagnosis in this patient is Turners (XO) syndrome. Absence of oocytes in the ovaries (streak ovaries) would be the histopathological finding in Turners syndrome.Increased serum FSH and absent breast indicates primary ovarian failure. This is mostly caused by 'Gondal Dysgenesis ' (Turner's syndrome). Elevated FSH is due to absence of ovarian oocytes and follicles leading to reduction in negative feedback on FSH from estradiol and inhibins A and B.Evaluation of Primary Amenorrhea:Primary amenorrhea is evaluated most efficiently by focusing on the presence or absence of:Breast Development:It is a marker of estrogen action and therefore function of the ovaryPresence or absence of uterus:As determined by ultrasound or in more complex cases by MRIEvaluation of Primary AmenorrheaBreast Development:Breast development and other secondary sexual characters are markers of estrogen action and therefore function of the ovaryPresence of breast and other secondary sexual features indicate normal estrogen level and normally functioning ovaryAbsence of Breast:Absence of breast indicates reduced estrogen levelThe cause of reduced estrogen level is then determined by measuring FSHIncreased serum FSH and absent breast indicates primary ovarian failure. This is mostly caused by 'Gondal Dysgenesis' (Turner's syndrome). Elevated FSH is due to absence of ovarian oocytes and follicles leading to reduction in negative feedback on FSH from estradiol and inhibins A and B.Absent breast with decreased serum FSH indicates primary amenorrhea due to hypothalamic or pituitary causes.Presence or absence of uterus:Further testing for a women with primary amenorrhea depends upon the findings on physical examination in particular whether mullerian structures are present or absent (Mullerian structures: Cervix, uterus, vagina, ovarian tube)The single most important step in the evaluation of primary amenorrhea depends upon the findings on physical examination or ultrasonography, whether there are any anatomic abnormalities of the vagina, cervix or uterus.Absence of Uterus:Absence of uterus usually means that Mullerian inhibitory substance was secreted at the time of Wolffian duct development.Mullerian inhibiting substance is usually secreted from the sertoli cells of the testis and it inhibits the development Wolffian duct or Mullerian duct structures.Absence of uterus suggests presence of MIs and is likely evidence of the presence of testis.For those with absence of the uterus, further evaluation should include a karyotype measurement and measurement of serum testosterone.These tests allow the clinician to distinguish between abnormal Mullerian development and androgen insensitivity syndrome.Absence of Uterus:For patients with normal Mullerian structures and no evidence of an imperforate hymen, vaginal septum, or congenital absence of vagina, an endocrine evaluation should be performed.This includes measurement of serum beta human chorionic gonadotropin to exclude pregnancy and of serum FSH and other hormones.A high serum FSH concentration is indicative of primary ovarian failure.A karyotype is then required to detect the presence of Turner's syndromeTurner's syndrome is characterized by the complete or partial deletion of X chromosome.In addition, evaluation for other diseases associated with specific type of ovarian failure should be performed.Low or normal FSH suggests functional hypothalamic amenorrhea, congenital GnPH deficiency or other disorders of hypothalamic pituitary axis.Serum prolactin is measured if galactorrhoea is present.If there are signs of hyperandrogenism, serum ketosterone and dehydroepiandrosterone sulfate (DHEAS) should be measured.Turners SyndromeMC karyotype is 45 XO, rest are 45XO/46XX, 45XO/46XY ( mosaics)Loss of one X chromosome is due to non-disjunctionQ during meiosis, the X chromosome retained is maternal in originQ in most cases.MC chromosome disorder in human beings.Presentation:Most affected fetus are aborted spontaneouslyQ (but MC chromosomal anomaly in 1st trimester is Trisomy)IUGR is common.In neonatal period:Slow growthQPresence of shield chest, cystic hygroma, lymphedemaQCardiac defects: Coarctation of aorta (MC), bicuspid aortic valve, mitral valve prolapse, aortic aneurysmQUrinary tract malformations, MC is Horse shoe shaped kidneyQAt Puberty:Primary amenorrhoea, failure to mature and infertilityQ.Absent secondary sexual characteristics (due to bilateral streak gonads, no estrogen secretion leading to undeveloped breast, absent axillary and pubic hair)QHormonal profile: Raised FSH and LH, decreased estrogen and progesteroneQElevated FSH is due to absence of ovarian oocytes and follicles leading to reduction in negative feedback on FSH from estradiol and inhibins A and B.Clinical features:Characteristic features are short stature, widely spaced nipples, webbed neckQAdditional features:Micrognathia, exaggerated epicanthal fold, low set earsQSensorineural hearing loss, otitis media (conductive hearing loss)QLow posterior hair line, colour blindness, high arched palateQBroad shield like chest, lack of breast development, shortened 4th metacarpalQCubitus valgusQ, hyperconvex nail, multiple pigmented naeviPatients are prone to:Colon cancerQAutoimmune disorders (Hashimotos thyroiditis, Addison's disease. Vitiligo)QHypertension, diabetes, thyroid disorders, osteoporosisQManagement:Administration of growth hormone to increase height.Exogenous estrogen at 12-13 years to start menstrual function.Progestin may be added to prevent endometrial hyperplasia.
47, XXY
47, XYY
45, XO
46, XY
Classification of DSD